The European Commission has launched a Manifesto to maximise the accessibility of research results in the fight against Covid-19.
The manifesto provides three guiding principles for beneficiaries of EU research grants for coronavirus prevention, testing, treatment and vaccination to ensure that their research results will be accessible for all and guarantee a return on public investment:
- Make the results public and accessible without delay, for instance on the Horizon Results Platform or through an existing patent pool;
- Make scientific papers and research data available in open access without delay and following the FAIR principles via preprint servers or public repositories, with rights for others to build upon the publications and data and with access to the tools needed for their validation;
- Where possible, grant time-limited, non-exclusive royalty free licences for the intellectual property until one year after the WHO declaration that coronavirus is no longer a 'Public Health Emergency of International Concern', with a maximum time limit of 1 January 2022, unless otherwise extended by the beneficiary.
Source: European Commission | Research and Innovation News (https://bit.ly/30lqnXL)